References
- Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11:889 - 96; http://dx.doi.org/10.1038/ni.1937; PMID: 20856220
- Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med 2011; 9:216; http://dx.doi.org/10.1186/1479-5876-9-216; PMID: 22176642
- Cavnar MJ, Zeng S, Kim TS, Sorenson EC, Ocuin LM, Balachandran VP, Seifert AM, Greer JB, Popow R, Crawley MH, et al. KIT oncogene inhibition drives intratumoral macrophage M2 polarization. J Exp Med 2013; 210:2873 - 86; http://dx.doi.org/10.1084/jem.20130875; PMID: 24323358
- Joensuu H, DeMatteo RP. The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy. Annu Rev Med 2012; 63:247 - 58; http://dx.doi.org/10.1146/annurev-med-043010-091813; PMID: 22017446
- Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, et al. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res 2005; 11:4182 - 90; http://dx.doi.org/10.1158/1078-0432.CCR-04-2245; PMID: 15930355
- Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG, Rosenthal N, Nerlov C. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci U S A 2009; 106:17475 - 80; http://dx.doi.org/10.1073/pnas.0908641106; PMID: 19805133